\-\ Texto\\:\\ \ \(0\)\
\-\ routine\\ laboratory\\ work\\ revealed\\ a\\ tsh\\ of\\ less\\ than\\ 0\\.019\\ \\(normal\\ range\\ \\-\\ 0\\.35\\-5\\.10\\)\\,\\ and\\ a\\ t4\\ of\\ 2\\.4\\ \\(normal\\ range\\ \\-\\ 0\\.89\\-1\\.76\\)\\.\\ further\\ history\\ revealed\\ that\\ she\\ has\\ family\\ history\\ of\\ hyperthyroidism\\.\\.\\ she\\ was\\ referred\\ to\\ endocrinology\\ with\\ an\\ initial\\ diagnosis\\ of\\ graves\\'\\ disease\\.\\ an\\ i\\-123\\ \\ thyroid\\ uptake\\ and\\ scan\\ was\\ ordered\\,\\ which\\ demonstrated\\ a\\ focal\\ hot\\ nodule\\ in\\ the\\ left\\ upper\\ lobe\\ with\\ the\\ remainder\\ of\\ the\\ gland\\ \\ relatively\\ suppressed\\.\\ patient\\ was\\ treated\\ with\\ inderal\\,\\ with\\ improvement\\ of\\ symptoms\\.\ \(0\)\
\-\ thyroid\\ uptake\\ and\\ scan\\ utilizing\\ 227\\.40\\ uci\\ of\\ i\\-123\\ administered\\ orally\\ was\\ performed\\.\\ pinhole\\ images\\ of\\ the\\ thyroid\\ gland\\ were\\ obtained\\ in\\ multiple\\ views\\ as\\ well\\ as\\ 4\\ and\\ 24\\ hour\\ radioactive\\ iodine\\ uptake\\ \\(raiu\\)\\ four\\ hour\\ uptake\\ was\\ calculated\\ at\\ 1\\.9\\%\\.\\ \\ the\\ 24\\ hour\\ uptake\\ was\\ calculated\\ at\\ 1\\.7\\%\\.\\ \\(normal\\ limits\\:\\ 5\\-15\\%\\ at\\ four\\ hours\\ and\\ 10\\-30\\%\\ at\\ twenty\\-four\\ hours\\)\\.\\ the\\ patient\\'s\\ neck\\ was\\ examined\\,\\ and\\ a\\ normal\\ sized\\ thyroid\\ gland\\ with\\ smooth\\ contours\\ and\\ normal\\ firmness\\ was\\ palpated\\.\\ \\ a\\ small\\,\\ firm\\,\\ immobile\\ approximately\\ 1cm\\ nontender\\ nodule\\ was\\ located\\ within\\ the\\ superior\\ portion\\ of\\ the\\ left\\ lobe\\ of\\ the\\ thyroid\\.\\ \ \(0\)\
\-\ \\ \\ \ \(31891\)\
\-\ pinhole\\ images\\ of\\ thyroid\\ gland\\ revealed\\ focal\\ uptake\\ within\\ the\\ superior\ \(0\)\
\-\ portion\\ of\\ the\\ left\\ lobe\\ of\\ the\\ thyroid\\.\\ \\ the\\ remainder\\ of\\ the\\ thyroid\\ gland\ \(0\)\
\-\ was\\ suppressed\\.\ \(1\)\
\-\ autonomous\\ functioning\\ thyroid\\ nodule\\.\ \(0\)\
\-\ adenomatous\\ hyperplasia\ \(1\)\
\-\ compensatory\\ thyroid\\ hyperplasia\ \(0\)\
\-\ physiologic\\ thyroid\\ hyperplasia\ \(0\)\
\-\ thyroid\\ carcinoma\\ \\(rare\\)\ \(0\)\
\-\ patient\\ is\\ is\\ a\\ 22\\ year\\ old\\ female\\ with\\ chief\\ complaints\\ of\\ anxiety\\ and\\ hyperhydrosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ thyroid\\:\\ 0\\.5280847141132086\ \(0\)\
\-\ uptake\\:\\ 0\\.2583511071759543\ \(0\)\
\-\ gland\\:\\ 0\\.22744361030548887\ \(0\)\
\-\ was\\:\\ 0\\.1951555854240776\ \(0\)\
\-\ of\\:\\ 0\\.16437589384214846\ \(0\)\
\-\ hour\\:\\ 0\\.1592915261914453\ \(0\)\
\-\ the\\:\\ 0\\.15642842540102664\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.15315418508869\ \(0\)\
\-\ pinhole\\:\\ 0\\.14750500453751378\ \(0\)\
\-\ calculated\\:\\ 0\\.13954447186329275\ \(0\)\
\-\ four\\:\\ 0\\.13613711657071897\ \(0\)\
\-\ nodule\\:\\ 0\\.13259582376442708\ \(0\)\
\-\ suppressed\\:\\ 0\\.12874536301318334\ \(0\)\
\-\ normal\\:\\ 0\\.11431628893574844\ \(0\)\
\-\ revealed\\:\\ 0\\.1101510782166794\ \(0\)\
\-\ remainder\\:\\ 0\\.09855567925131631\ \(0\)\
\-\ lobe\\:\\ 0\\.09708129365798214\ \(0\)\
\-\ and\\:\\ 0\\.09256899133849564\ \(0\)\
\-\ range\\:\\ 0\\.08690773678342326\ \(0\)\
\-\ inderal\\:\\ 0\\.08557135505787698\ \(0\)\
\-\ hyperhydrosis\\:\\ 0\\.08557135505787698\ \(0\)\
\-\ hours\\:\\ 0\\.08535695025059285\ \(0\)\
\-\ at\\:\\ 0\\.08460331843811969\ \(0\)\
\-\ portion\\:\\ 0\\.08008522710781572\ \(0\)\
\-\ 24\\:\\ 0\\.07940064434013881\ \(0\)\
\-\ orally\\:\\ 0\\.0772538177808956\ \(0\)\
\-\ firmness\\:\\ 0\\.0772538177808956\ \(0\)\
\-\ autonomous\\:\\ 0\\.0772538177808956\ \(0\)\
\-\ uci\\:\\ 0\\.07375250226875689\ \(0\)\
\-\ immobile\\:\\ 0\\.07281688563326108\ \(0\)\
\-\ superior\\:\\ 0\\.07281213758913171\ \(0\)\
\-\ endocrinology\\:\\ 0\\.06913869065735796\ \(0\)\
\-\ compensatory\\:\\ 0\\.06913869065735796\ \(0\)\
\-\ radioactive\\:\\ 0\\.06745171493739908\ \(0\)\
\-\ contours\\:\\ 0\\.06745171493739908\ \(0\)\
\-\ focal\\:\\ 0\\.06698991923504051\ \(0\)\
\-\ utilizing\\:\\ 0\\.06694819202288038\ \(0\)\
\-\ raiu\\:\\ 0\\.06694819202288038\ \(0\)\
\-\ she\\:\\ 0\\.06666752957246334\ \(0\)\
\-\ scan\\:\\ 0\\.06644496585289403\ \(0\)\
\-\ with\\:\\ 0\\.0657896433598202\ \(0\)\
\-\ hot\\:\\ 0\\.06475769338840279\ \(0\)\
\-\ adenomatous\\:\\ 0\\.06475769338840279\ \(0\)\
\-\ anxiety\\:\\ 0\\.06437268150659167\ \(0\)\
\-\ physiologic\\:\\ 0\\.06400220189190295\ \(0\)\
\-\ hyperthyroidism\\:\\ 0\\.06296792568576987\ \(0\)\
\-\ examined\\:\\ 0\\.06203230905027406\ \(0\)\
\-\ functioning\\:\\ 0\\.06203230905027406\ \(0\)\
\-\ graves\\:\\ 0\\.0617392561046283\ \(0\)\
\-\ iodine\\:\\ 0\\.0617392561046283\ \(0\)\
\-\ palpated\\:\\ 0\\.06014388177700387\ \(0\)\
\-\ 1cm\\:\\ 0\\.059433942773605926\ \(0\)\
\-\ chief\\:\\ 0\\.05920826514150806\ \(0\)\
\-\ administered\\:\\ 0\\.05795338314252628\ \(0\)\
\-\ left\\:\\ 0\\.05730553976534599\ \(0\)\
\-\ sized\\:\\ 0\\.057197891646026434\ \(0\)\
\-\ t4\\:\\ 0\\.05616361543989335\ \(0\)\
\-\ patient\\:\\ 0\\.05463917795892805\ \(0\)\
\-\ tsh\\:\\ 0\\.05410488448382256\ \(0\)\
\-\ nontender\\:\\ 0\\.052744447224274196\ \(0\)\
\-\ images\\:\\ 0\\.051804812965866934\ \(0\)\
\-\ within\\:\\ 0\\.051581114123886294\ \(0\)\
\-\ firm\\:\\ 0\\.05076406101483864\ \(0\)\
\-\ ordered\\:\\ 0\\.04919704456340597\ \(0\)\
\-\ improvement\\:\\ 0\\.048880354369045045\ \(0\)\
\-\ smooth\\:\\ 0\\.04623318992404346\ \(0\)\
\-\ complaints\\:\\ 0\\.04611491687106044\ \(0\)\
\-\ work\\:\\ 0\\.04565557952843438\ \(0\)\
\-\ relatively\\:\\ 0\\.045599644649755036\ \(0\)\
\-\ as\\:\\ 0\\.044992078966010755\ \(0\)\
\-\ located\\:\\ 0\\.04429580222684441\ \(0\)\
\-\ limits\\:\\ 0\\.04424708478368682\ \(0\)\
\-\ views\\:\\ 0\\.04419860792147569\ \(0\)\
\-\ 22\\:\\ 0\\.04410236651679433\ \(0\)\
\-\ family\\:\\ 0\\.04405459734881602\ \(0\)\
\-\ routine\\:\\ 0\\.04336462646210898\ \(0\)\
\-\ an\\:\\ 0\\.04282623861281293\ \(0\)\
\-\ history\\:\\ 0\\.042788300264202245\ \(0\)\
\-\ rare\\:\\ 0\\.042272775049003265\ \(0\)\
\-\ referred\\:\\ 0\\.04143519758811334\ \(0\)\
\-\ laboratory\\:\\ 0\\.04066350048389115\ \(0\)\
\-\ obtained\\:\\ 0\\.039609004817162896\ \(0\)\
\-\ less\\:\\ 0\\.03809577778605802\ \(0\)\
\-\ initial\\:\\ 0\\.037565024494443655\ \(0\)\
\-\ further\\:\\ 0\\.03647187827890271\ \(0\)\
\-\ approximately\\:\\ 0\\.035730254841303245\ \(0\)\
\-\ treated\\:\\ 0\\.03487100294544736\ \(0\)\
\-\ demonstrated\\:\\ 0\\.03441433713492335\ \(0\)\
\-\ neck\\:\\ 0\\.0342550028852101\ \(0\)\
\-\ carcinoma\\:\\ 0\\.033494959617520255\ \(0\)\
\-\ performed\\:\\ 0\\.03312809234680914\ \(0\)\
\-\ than\\:\\ 0\\.031743187988057656\ \(0\)\
\-\ is\\:\\ 0\\.030670395811209016\ \(0\)\
\-\ symptoms\\:\\ 0\\.030638464291933794\ \(0\)\
\-\ upper\\:\\ 0\\.029924005700680517\ \(0\)\
\-\ diagnosis\\:\\ 0\\.02902852175290686\ \(0\)\
\-\ small\\:\\ 0\\.028885211986576134\ \(0\)\
\-\ were\\:\\ 0\\.028864908888028618\ \(0\)\
\-\ in\\:\\ 0\\.027860543409018376\ \(0\)\
\-\ multiple\\:\\ 0\\.027389421096198144\ \(0\)\
\-\ well\\:\\ 0\\.02711409241857847\ \(0\)\
\-\ female\\:\\ 0\\.027021203991192604\ \(0\)\
\-\ has\\:\\ 0\\.025577863052434986\ \(0\)\
\-\ which\\:\\ 0\\.025462457818534123\ \(0\)\
\-\ that\\:\\ 0\\.024300659844375506\ \(0\)\
\-\ disease\\:\\ 0\\.02350561108773419\ \(0\)\
\-\ year\\:\\ 0\\.017257216814335483\ \(0\)\
\-\ old\\:\\ 0\\.016572901875609964\ \(0\)\
\-\ to\\:\\ 0\\.01399917561790724\ \(0\)\
